ClinicalTrials.gg
Not yet recruitingNCT07566715Updated May 5, 2026

Pilates vs Aerobic Exercises on Vitamin D and Ionized Calcium in Postnatal

An interventional study of Exercise and Exercise in Postnatal Women and Vitamin D, sponsored by Adly A Adam. Not yet recruiting at 2 sites in Egypt. Open to female participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-05.

Sponsored by Adly A Adam · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

Vitamin D and calcium levels are negatively affected during postpartum period, making postnatal woman more vulnerable to health issues and consequently lowering her quality of life. Twelve-weeks of Pilates training have improved serum 25-hydroxy vitamin D levels and changed anthropometry in inactive overweight women. It is well-known globally that aerobic exercise is low to moderate-intensity physical activity.

Read the detailed description

This study will be conducted to determine the difference between the effect of Pilates and aerobic exercises on serum levels of vitamin D, ionized calcium and osteocalcin in postnatal women. The practical aspect of the study will be conducted at the Out Patient Clinic of Al-Zahraa University Hospital, Al Azahar University, Cairo, Egypt. Sixty postnatal women will participate in this study. Their ages range will be from 18 to 40 and their BMI range will be from 25-35 kg/ m². All women will be postnatal period by 6-12 weeks, as well healthy primipara or multipara. The participants will be randomly assign into two equal groups by using a sealed envelope method; group A (Pilates exercises group) will include thirty postnatal women, whom will perform Pilates exercises for 12 weeks, and group (B), (Aerobic exercises group)will include thirty postnatal women, whom will perform aerobic exercises program for 12 weeks. Will assess vitamin D, Ionized calcium and osteocalcin for all participants at the start and after the treatment program, then will statistically analyze the data.

02

Conditions studied

  • Postnatal Women
  • Vitamin D
03

In context

Lead sponsor

Adly A Adam is the lead sponsor of 12 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Their ages were ranged from 18-40 years old.
  2. Their (BMI) was ranged from 25-35 kg/ m².
  3. They were postnatal period by 6-12 weeks.
  4. They were primipara or multipara.
  5. They were healthy postpartum women.

Exclusion criteria

Exclusion Criteria:

  1. High risk pregnant history.
  2. Sever postpartum complications.
  3. Cardiovascular diseases i.e., utilizing pace maker.
  4. Skeletal deformity.
  5. Participation at any other exercise training program during this study.
  6. Malignant conditions.
  7. History of acute infection
  8. Neurological problem; epileptic fits…etc.
  9. Mental problem to prevent evaluation and cooperation.
  10. Renal, liver or endocrinal disorders.
  11. Pulmonary disorders.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Experimental Group A (Pilates exercises group)

    Experimental Group A (Pilates exercises group) will be thirty postnatal women will perform Pilates exercises for 12 weeks, 3 sessions per week for 60 minutes

    Other: Exercise

  • Experimental
    Experimental Group B(Aerobic exercises group)

    Experimental Group B(Aerobic exercises group) will be thirty postnatal women will perform aerobic exercises for 12 weeks, 3 sessions per week for 60 minutes

    Other: Exercise

Interventions

  • OtherExercise

    Pilates exercises program will include twelve movements: Bridging, Roll Up, Pilates Hundred, One Leg Circle (both ways), Single Straight Leg Stretch, Double Leg Stretch, Spine Stretch Forward Single Leg Kick, Side Kick up and down, Side Kick circles, Curling.

  • OtherExercise

    20 minutes walking on the treadmill at moderate intensity (70% of the maximal heart rate).

06

What researchers measure

Primary outcomes

  1. Vitamin D serum level

    High-performance liquid chromatography (Shimadzu, Japan) was used to assess 25(OH)D serum levels before and after the study program in both groups, using 25-OH vitamin D ELISA. Kits (Life Sciences Inc. USA). Values of 25(OH)D \< 20 ng/ml are considered deficient, values ranged 21 to 29 ng/ml are considered insufficient, and 30 ng/ml is considered ideal

    Time frame: At baseline, and Immediately post-intervention

Secondary outcomes

  1. Ionized calcium serum level

    serum ionized calcium levels measured before and after the intervention, using Easy Lyte Ca analyzer (USA) which utilizes ISE (Ion Selective Electrode) technology in order to measure electrolyte. The manufacturer's instructions were followed at all times. In adults (18-60 years), the reference value of serum calcium is 1.05-1.3 mmol/L

    Time frame: At baseline, and Immediately post-intervention

07

Study locations

2 sites
  • AlZahraa University Hospital
    Cairo, Al Zahraa University Hospital 11731, Egypt
    • Afaf M Botla, Professor · Contacteth.com@pt.cu.edu.eg · 00201001352075
    • Mohamed A Awad, Professor · Contacteth.com@pt.cu.edu.eg · 00201001352075
    • Ahmed T Tolba, M.S.c · Principal investigator
    • Abdel Hamid A Atta Allah, Professor · Sub investigator
  • AlZahraa University Hospital
    Cairo, Al Zahraa University Hospital 11731, Egypt
    • Mohamed A Awad, Professor · Contacteth.com@pt.cu.edu.eg · +20100135075
    • Afaf M Botla, Professor · Contacteth.com@pt.cu.edu.eg · +20100135075
    • Ahmed A Tolba, M.S.c · Principal investigator
    • AbdelHamid A AttaAllah, PRofessor · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07566715
Lead sponsor
Adly A Adam
Responsible party
Adly A Adam (Lecture of Physical Therapy, Cairo University) — Sponsor-investigator
First posted
May 5, 2026
Start date
May 1, 2026 (estimated)
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
May 5, 2026

Study contacts

Ahmed A Tolba, M.Sc.
Contact
eth.com@pt.cu.edu.eg
+20100352075 ext. 105
Afaf M Botla, Professor
Contact
eth.com@pt.cu.edu.eg
+20100352075 ext. 105
Mohamed A Awad, Professor
study director · Cairo University
AbdelHamid A AttalAllah, Professor
study chair · AlZahraaUniversity

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion